Contents

Current Pharmaceutical Design, Volume 13 - Number 22

Editorial [Hot Topic: COX-2 Inhibition in Gastroenterology and Rheumatolgy:Current Challenges and Perspectives for the Future (Executive Editor: Angel Lanas)]

, 13(22): 2214

Angel Lanas


DOI: 10.2174/138161207781368765




Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks

, 13(22): 2215 - 2227

Jose Martinez-Gonzalez and Lina Badimon


DOI: 10.2174/138161207781368774




Efficacy of the Newest COX-2 Selective Inhibitors in Rheumatic Disease

, 13(22): 2228 - 2236

Herbert S.B. Baraf


DOI: 10.2174/138161207781368819




Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib

, 13(22): 2237 - 2247

Yuhong Yuan and Richard H. Hunt


DOI: 10.2174/138161207781368792




How to Advise Aspirin Use in Patients Who Need NSAIDs

, 13(22): 2248 - 2260

F. Sopena and A. Lanas


DOI: 10.2174/138161207781368837




Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

, 13(22): 2261 - 2273

Pilar Jimenez, Asuncion Garcia, Sonia Santander and Elena Piazuelo


DOI: 10.2174/138161207781368800




Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention

, 13(22): 2274 - 2282

Ben Boursi and Nadir Arber


DOI: 10.2174/138161207781368783




Development of Novel Inhibitors Targeting Intracellular Steps of Peptidoglycan Biosynthesis

, 13(22): 2283 - 2309

Miha Kotnik, Petra Stefanic Anderluh and Andrej Prezelj


DOI: 10.2174/138161207781368828




Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury

, 13(22): 2310 - 2322

Juan Sahuquillo and Anna Vilalta


DOI: 10.2174/138161207781368756




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science